Kane Biotech, Inc. (KNBIF)
0.0201
0.00 (0.00%)
USD |
OTCM |
Jun 08, 16:00
Kane Biotech SG&A Expense (Quarterly) : 0.3358M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Edesa Biotech, Inc. | 1.530M |
| ProMIS Neurosciences, Inc. | 1.674M |
| Arrowhead Pharmaceuticals, Inc. | 41.74M |
| Oncolytics Biotech, Inc. | 4.729M |
| Sangamo Therapeutics, Inc. | 6.818M |